Evidence map›Paper›PMID 34299519›Full record

ReviewMolecules (Basel, Switzerland)2021

Enhancement of Biological and Pharmacological Properties of an Encapsulated Polyphenol: Curcumin.

Bwalya Angel Witika, Pedzisai Anotida Makoni, Scott Kaba Matafwali, Larry Lawrence Mweetwa, Ginnethon Chaamba Shandele, Roderick Bryan Walker

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. The Polymorphs of Diacetylcurcumin (DAC).Molecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Current State of Scientific Knowledge on Curcumin Encapsulation and Applications.Recent advances in food, nutrition & agriculture · 2025
    Review
  10. Review
  11. Review
  12. Roseoside Is a Bioactive Compound inMolecules (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. The Homoleptic Curcumin-Copper Single Crystal (MLMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Bwalya Angel WitikaApotheCom|A MEDiSTRAVA Company (Medical Division of Huntsworth), London WC2A 1AN, UK.ORCID 0000-0002-4034-9368
Pedzisai Anotida MakoniDivision of Pharmacology, Faculty of Pharmacy, Rhodes University, Makhanda 6140, South Africa.ORCID 0000-0002-8475-447X
Scott Kaba MatafwaliClinical Research Department, Faculty of Infectious and Tropical Diseases, LSHTM, London WC1E 7HT, UK.ORCID 0000-0001-9921-7039
Larry Lawrence MweetwaDepartment of Chemistry, Marine Biodiscovery Centre, University of Aberdeen, Aberdeen AB24 3FX, UK.
Ginnethon Chaamba ShandeleDepartment of Biochemistry, Institute of Basic and Biomedical Sciences, Levy Mwanawasa Medical University, P.O. Box 33991, Lusaka 10101, Zambia.
Roderick Bryan WalkerDivision of Pharmaceutics, Faculty of Pharmacy, Rhodes University, Makhanda 6140, South Africa.ORCID 0000-0003-2781-4154
Rhodes University · ZALondon School of Hygiene & Tropical Medicine · GBLusaka Apex Medical University · ZMUniversity of Aberdeen · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a dearth of natural remedies available for the treatment of an increasing number of diseases facing mankind. Natural products may provide an opportunity to produce formulations and therapeutic solutions to address this shortage. Curcumin (CUR), diferuloylmethane; I,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione is the major pigment in turmeric powder which has been reported to exhibit a number of health benefits including, antibacterial, antiviral, anti-cancer, anti-inflammatory and anti-oxidant properties. In this review, the authors attempt to highlight the biological and pharmacological properties of CUR in addition to emphasizing aspects relating to the biosynthesis, encapsulation and therapeutic effects of the compound. The information contained in this review was generated by considering published information in which evidence of enhanced biological and pharmacological properties of nano-encapsulated CUR was reported. CUR has contributed to a significant improvement in melanoma, breast, lung, gastro-intestinal, and genito-urinary cancer therapy. We highlight the impact of nano-encapsulated CUR for efficient inhibition of cell proliferation, even at low concentrations compared to the free CUR when considering anti-proliferation. Furthermore nano-encapsulated CUR exhibited bioactive properties, exerted cytotoxic and anti-oxidant effects by acting on endogenous and cholinergic anti-oxidant systems. CUR was reported to block Hepatitis C virus (HCV) entry into hepatic cells, inhibit MRSA proliferation, enhance wound healing and reduce bacterial load. Nano-encapsulated CUR has also shown bioactive properties when acting on antioxidant systems (endogenous and cholinergic). Future research is necessary and must focus on investigation of encapsulated CUR nano-particles in different models of human pathology.

Indexed as

Drug Delivery SystemsAnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsBiological AvailabilityCurcuminDelayed-Action PreparationsDrug CarriersHumansPolyphenolsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAntioxidantsCurcuminDelayed-Action PreparationsDrug CarriersPolyphenolsanti-inflammatoryanti-oxidantanti-viralcancer therapycurcuminencapsulationenhanced bioavailabilitypolyphenolssustained releasetargeted delivery

Identifiers

PMID34299519
PMCPMC8303961
OpenAlexW3183032944

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.